• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

作者信息

Tan David, Fujiwara Noriko, Fujiwara Keiichi, Beale Philip, Kim Jae-Weon, Ng Joseph, Kim Se Ik, Evans Alison, Kim Byoung-Gie

机构信息

Department of Haematology-Oncology, National University Cancer Institute Singapore, Singapore.

Cancer Science Institute, National University of Singapore, Singapore.

出版信息

J Gynecol Oncol. 2023 Mar;34(2):e33. doi: 10.3802/jgo.2023.34.e33.

DOI:10.3802/jgo.2023.34.e33
PMID:36890293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995874/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/69355650f0e2/jgo-34-e33-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/f1c20364cd0a/jgo-34-e33-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/5c044e9514e7/jgo-34-e33-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/69355650f0e2/jgo-34-e33-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/f1c20364cd0a/jgo-34-e33-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/5c044e9514e7/jgo-34-e33-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3467/9995874/69355650f0e2/jgo-34-e33-g003.jpg

相似文献

1
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.亚太妇科肿瘤试验组（APGOT）：构建一个泛亚和大洋洲女性癌症研究组织。
J Gynecol Oncol. 2023 Mar;34(2):e33. doi: 10.3802/jgo.2023.34.e33.
2
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.亚太妇科肿瘤试验组（APGOT）：构建一个泛亚和大洋洲的女性癌症研究组织。
Int J Gynecol Cancer. 2023 Apr 3;33(4):628-630. doi: 10.1136/ijgc-2022-004236.
3
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.勘误：亚太妇科肿瘤试验组（APGOT）：建立一个泛亚和大洋洲妇女癌症研究组织。
J Gynecol Oncol. 2025 Sep 3. doi: 10.3802/jgo.2025.36.e131.
4
The AOFOG declaration on violence against women: A regional call to action for Asia and Oceania.
J Obstet Gynaecol Res. 2025 Aug;51(8):e70004. doi: 10.1111/jog.70004.
5
Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials.妇科肿瘤学 3 期临床试验中女性主要研究者（PI）的代表性趋势和地域差异。
Gynecol Oncol. 2021 Aug;162(2):389-393. doi: 10.1016/j.ygyno.2021.05.037. Epub 2021 Jun 5.
6
When Impact Multiplies: Defining Trials and Insights from the 2025 Society of Gynecologic Oncology Annual Meeting.当影响力成倍增长：定义试验及来自2025年妇科肿瘤学会年会的见解
Int J Gynecol Cancer. 2025 Jul;35(7):101895. doi: 10.1016/j.ijgc.2025.101895. Epub 2025 Apr 22.
7
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.东亚妇科肿瘤协作组（EAGOT）：创立历史与未来展望。
J Gynecol Oncol. 2023 Sep;34(5):e86. doi: 10.3802/jgo.2023.34.e86. Epub 2023 Aug 4.
8
Asian Society of Gynecologic Oncology International Workshop 2018.亚洲妇科肿瘤学会国际研讨会 2018 年。
J Gynecol Oncol. 2019 Mar;30(2):e39. doi: 10.3802/jgo.2019.30.e39. Epub 2019 Jan 14.
9
Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis.亚洲和大洋州多发性硬化症的流行病学; 系统评价和荟萃分析。
Mult Scler Relat Disord. 2021 Sep;54:103119. doi: 10.1016/j.msard.2021.103119. Epub 2021 Jun 30.
10
Status of cancer treatment by radiotherapy and requirement of radiation oncology medical physicists in Asia Oceania federation of organizations for medical physics region.亚洲大洋洲医学物理组织联合会地区放射治疗的癌症治疗现状及放射肿瘤医学物理师的需求
J Cancer Res Ther. 2023 Apr-Jun;19(3):567-572. doi: 10.4103/jcrt.jcrt_51_21.

引用本文的文献

1
Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia.亚洲妇科肿瘤学会（ASGO）2024年年会在印度尼西亚巴厘岛举行。
J Gynecol Oncol. 2025 Mar;36(2):e97. doi: 10.3802/jgo.2025.36.e97. Epub 2025 Mar 10.

本文引用的文献

1
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01).奥拉帕利维持治疗联合帕博利珠单抗和贝伐珠单抗治疗非突变型铂敏感复发性卵巢癌患者的单臂 II 期研究（OPEB-01）。
J Gynecol Oncol. 2021 Mar;32(2):e31. doi: 10.3802/jgo.2021.32.e31. Epub 2021 Jan 27.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Joint ENGOT and GOG Foundation requirements for trials with industry partners.
ENGOT与妇科肿瘤学组基金会（GOG Foundation）对与行业合作伙伴开展试验的联合要求。
Int J Gynecol Cancer. 2019 Sep;29(7):1094-1097. doi: 10.1136/ijgc-2019-000441. Epub 2019 Jul 18.
4
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.欧洲妇科肿瘤试验组织网络对学术团体与行业合作伙伴间试验的要求——2015年首次更新
Int J Gynecol Cancer. 2015 Sep;25(7):1328-30. doi: 10.1097/IGC.0000000000000478.
5
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.欧洲妇科临床试验网络（ENGOT）试验路线图。
Int J Gynecol Cancer. 2013 Sep;23(7):1339-43. doi: 10.1097/IGC.0b013e31829b87da.